References
- Cheung AP. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol 2001;98:325–31
- Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001;7:522–5
- Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403–7
- Sit AS, Modugno F, Hill LM, et al. Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. Cancer Epidemiol Biomarkers Prev 2004;13:1459–65
- Chiazze L Jr, Brayer FT, Macisco JJ Jr, et al. The length and variability of the human menstrual cycle. JAMA. 1968;203:377–80
- Lin YH, Chiu WC, Wu CH, et al. Anti-Müllerian hormone and polycystic ovary syndrome. Fertil Steril 2011;96:230--5
- Tingthanatikul Y, Choktanasiri W, Rochanawutanon M, Weerakeit S. Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea. Gynecol Endocrinol 2006;22:101–5
- Campbell BK, Clewes JS, Kendall NR, Johnson IR. Defining endometrial growth during the menstrual cycle with three-dimensional ultrasound. BJOG 2004;111:944–9
- Barash A, Weissman A, Manor M, et al. Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program. Fertil Steril 1998;69:496–9
- Iatrakis G, Tsionis C, Adonakis G, et al. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol 2006;127:218–21
- Andolf E, Dahlander K, Aspenberg P. Ultrasonic thickness of the endometrium correlated to body weight in asymptomatic postmenopausal women. Obstet Gynecol 1993;82:936–40
- Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810–2